Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1616628-98-8

Post Buying Request

1616628-98-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1616628-98-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1616628-98-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,6,6,2 and 8 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1616628-98:
(9*1)+(8*6)+(7*1)+(6*6)+(5*6)+(4*2)+(3*8)+(2*9)+(1*8)=188
188 % 10 = 8
So 1616628-98-8 is a valid CAS Registry Number.

1616628-98-8Downstream Products

1616628-98-8Relevant articles and documents

Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors

Daydé-Cazals, Bénédicte,Fauvel, Bénédicte,Singer, Mathilde,Feneyrolles, Clémence,Bestgen, Benoit,Gassiot, Fanny,Spenlinhauer, Aurélia,Warnault, Pierre,Van Hijfte, Nathalie,Borjini, Nozha,Chevé, Gwéna?l,Yasri, Abdelaziz

, p. 3886 - 3905 (2016/05/24)

Efforts were made to improve a series of potent dual ABL/SRC inhibitors based on a 7-azaindole core with the aim of developing compounds that demonstrate a wider activity on selected oncogenic kinases. Multi-targeted kinase inhibitors (MTKIs) were then derived, focusing on kinases involved in both angiogenesis and tumorigenesis processes. Antiproliferative activity studies using different cellular models led to the discovery of a lead candidate (6z) that combined both antiangiogenic and antitumoral effects. The activity of 6z was assessed against a panel of kinases and cell lines including solid cancers and leukemia cell models to explore its potential therapeutic applications. With its potency and selectivity for oncogenic kinases, 6z was revealed to be a focused MTKI that should have a bright future in fighting a wide range of cancers.

AZAINDOLE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES

-

Page/Page column 40-41, (2014/07/21)

The present invention relates to compounds of the following formula (I) and/or the pharmaceutically acceptable addition salts, solvates, enantiomers, diastereoisomers thereof, as well as mixtures thereof. The subject matter of the present invention thus a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1616628-98-8